Desjardins Global Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$57.1K Buy
433
+6
+1% +$791 0.01% 519
2023
Q3
$48K Buy
+427
New +$48K 0.01% 538